Immunogenicity and safety of homologous and heterologous ChAdOx1-S and mRNA-1273 vaccinations in healthy adults in Taiwan
Journal
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
Journal Volume
150-151
Date Issued
2022-06
Author(s)
Lee, Nan-Yao
Lin, Chih-Hsueh
Hsu, Yuan-Shan
Chang, Yu-Chang
Chung, Ming-Yi
Lee, Ya-Fan
Lu, Min-Chi
Ko, Wen-Chien
Abstract
In Taiwan, the vaccination program started in March 2021, with ChAdOx1-S being the first available WHO-approved COVID-19 vaccine, followed by Moderna vaccine. This study aimed to investigate the immunogenicity and safety of homologous and heterologous prime-boost regimens with ChAdOx1-S and mRNA-1273.
Subjects
COVID-19 vaccines; Homologous and heterologous prime-boost regimens; Immunogenicity; Safety
SDGs
Publisher
ELSEVIER
Type
journal article